Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01200849 · ClinicalTrials.gov registry record · NA

Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
420
Enrollment target

NCT01200849: Completed NA study, sponsored by Northwestern University.

NCT01200849 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 420 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01200849, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
420 participants
Enrollment target

Study Summary

The overall objective of this study is to test the efficacy of an evidence-based, enhanced Rx container label design to improve Spanish speaking patients' understanding of instructions for use.

Primary Outcome

Difference in understanding and comprehension of medication use as compared to control.

Interventions

  • OTHER Enhanced Label

Trial Details

FieldValue
Enrollment Target 420 participants
Start Date 2010-10
Est. Completion 2014-01
Phase NA
Northwestern University

1,209 total trials

What the finished NCT01200849 record still lists

NCT01200849 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).

The record links to 0 conditions, and to 1 intervention - of which Enhanced Label is the first listed.

NCT01200849 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01200849 about?

NCT01200849 is a clinical study titled "Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use". The overall objective of this study is to test the efficacy of an evidence-based, enhanced Rx container label design to improve Spanish speaking patients' understanding of instructions for use.

What is the current status of trial NCT01200849?

This trial is currently completed. It is a NA study. The enrollment target is 420 participants. The study started on 2010-10. Estimated completion is 2014-01.

What interventions are being tested in trial NCT01200849?

The interventions under investigation include: Enhanced Label (OTHER).

Who is sponsoring clinical trial NCT01200849?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01200849's enrollment target sits among peer trials

420 239th of 2000 higher than 1,761 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01790152 · 420 participants

    Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • NCT02701244 · 420 participants

    A Registry Study of Breast Microseed Treatment

  • NCT02966665 · 420 participants · Phase 1

    : Vascular Function in Health and Disease

  • NCT04149743 · 420 participants · NA

    HEMOTAG® Assessment for Short-term Outcomes of Heart Failure

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01200849, the US trial registry maintained by the National Library of Medicine. NCT01200849 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.